NCT06866964 2026-02-02
ASPIRE
Wake Forest University Health Sciences
Phase 2 Recruiting
Clinical Trials
11 trialsNCT03899987 2025-08-27
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
Roswell Park Cancer Institute
Phase 2 Active not recruiting
NCT03819101 2025-06-26
PEACE-4
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT02804815 2025-06-10
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
Phase 3 Active not recruiting
NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT02420652 2023-02-08
PRIMA
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT00055731 2023-01-18
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
UNICANCER
Phase 3 Completed
NCT02350543 2019-04-08
Peri-operative Aspirin Continuation Versus Discontinuation
Rabin Medical Center
Phase 4 Terminated
NCT00234299 2016-05-25
Effects of ASA on Prostate Tissue
University of Washington
Phase NA Completed
NCT02757365 2016-05-02
Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer
West China Hospital
Phase 4 Unknown
NCT00316927 2013-06-26
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Completed